Procaps Group S.A - Warrants (29/09/2026) Return on Equity

Procaps Group S.A - Warrants (29/09/2026) (PROCW) currently reports a ROE of 1.33%. That is above the Healthcare sector average of 29.03%. Use the charts on this page to explore Procaps Group S.A - Warrants (29/09/2026)'s ROE history and peer comparisons.

Procaps Group S.A - Warrants (29/09/2026)'s ROE of 1.33% is higher than the Healthcare sector average of 29.03%. That is roughly 356.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Procaps Group S.A - Warrants (29/09/2026)'s current 1.33% should be judged against Healthcare norms (sector average: 29.03%) and against PROCW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 1.33%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.03%. From there, open related valuation or income-statement pages for Procaps Group S.A - Warrants (29/09/2026), and consider following PROCW for alerts when major investors trade the stock.

Procaps Group S.A - Warrants (29/09/2026) is classified in the Healthcare sector. On ROE, it currently shows 1.33% versus a sector average near 29.03%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PROCW with unrelated industries.